MiRNAs Mediate GDNF-Induced Proliferation and Migration of Glioma Cells

Abstract

Background/Aims: Glial cell line-derived neurotrophic factor (GDNF) is an important factor promoting invasive glioma growth. This study was performed to reveal a unique mechanism of glioma cell proliferation and migration. Methods: Human U251 glioma cells were used to screen the optimal GDNF concentration and treatment time to stimulate proliferation and migration. MicroRNA (MiRNA) expression profiles were detected by microarray and confirmed by real-time polymerase chain reaction (PCR). The target genes of differentially expressed miRNAs were predicted by miRWalk, and those targeted by multiple miRNAs were screened with Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. A regulatory miRNA network was constructed using ingenuity pathway analysis (IPA). Target gene expression of differentially expressed miRNAs was examined by real-time PCR or mRNA microarray. Results: The results show that 50 ng/mL GDNF for 24 h significantly promotes U251 glioma cell proliferation and migration (P < 0.05). Seven miRNAs (hsa-miR-194-5p, hsa-miR-152-3p, hsa-miR-205-5p, hsa-miR-629-5p, hsa-miR-3609, hsa-miR-183-5p, and hsa-miR-487b-3p) were significantly up-regulated after GDNF treatment (P < 0.05). These miRNAs are primarily involved in signal transduction, cell adhesion and cell cycle through mitogen-activated protein kinase (MAPK) signaling, focal adhesion and glioma signal pathways. Five of these miRNAs (hsa-miR-194-5p, hsa-miR-152-3p, hsa-miR-205-5p, hsa-miR-183-5p, and hsa-miR-487b-3p) co-regulate TP53 and Akt. mRNA expression levels of four genes co-targeted by two or more up-regulated miRNAs were significantly decreased after GDNF treatment (P < 0.05). Conclusion: GDNF treatment of U251 glioma cells significantly increased the expression of seven miRNAs involved in cell adhesion and the cell cycle.

A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients

“…Particularly, the glioblastoma multiforme (GBM, WHO Grade IV) is considered to be one of the most malignant tumors in human cancers [3]. One of the main obstacles of treating gliomas is that the tumor is highly invasive which leads to rapid recurrence or progression [4]. Therefore, it is necessary to discover new functional targets in glioma carcinogenesis and develop effective biological molecular therapies correspondingly.…”

miR-16-2* Interferes with WNT5A to Regulate Osteogenesis of Mesenchymal Stem Cells

“…Recently, miRNAs have been found to be important regulators of osteogenic signaling pathways in multiple aspects and multiple signaling pathways. MiRNAs are short non-coding RNA molecules of 17-25 nucleotides that control gene expression at the post-transcriptional level and have been shown to play critical roles in a wide variety of biological processes, including proliferation, reprogramming, differentiation, cell cycle, invasion and apoptosis [6,7,9,[42][43][44]. Each miRNA regulates numerous mRNAs and involve multiple signaling pathways.…”

MicroRNA-29a-3p Downregulation Causes Gab1 Upregulation to Promote Glioma Cell Proliferation

“…The significance of miRs in diagnostic and prognostic determination has been demonstrated in glioma [20][21][22] and a number of other human cancers [51,52]. In the current study, we provided the quantitative description of a potential relationship between decreased miR-29-3p expression and the grade of malignant glioma patients.…”